These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2159339)
1. Sequence-specific 1H NMR assignments and secondary structure of eglin c. Hyberts SG; Wagner G Biochemistry; 1990 Feb; 29(6):1465-74. PubMed ID: 2159339 [TBL] [Abstract][Full Text] [Related]
2. The solution structure of eglin c based on measurements of many NOEs and coupling constants and its comparison with X-ray structures. Hyberts SG; Goldberg MS; Havel TF; Wagner G Protein Sci; 1992 Jun; 1(6):736-51. PubMed ID: 1304915 [TBL] [Abstract][Full Text] [Related]
3. Changing the inhibitory specificity and function of the proteinase inhibitor eglin c by site-directed mutagenesis: functional and structural investigation. Heinz DW; Hyberts SG; Peng JW; Priestle JP; Wagner G; Grütter MG Biochemistry; 1992 Sep; 31(37):8755-66. PubMed ID: 1390662 [TBL] [Abstract][Full Text] [Related]
4. The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry. Bode W; Papamokos E; Musil D Eur J Biochem; 1987 Aug; 166(3):673-92. PubMed ID: 3301348 [TBL] [Abstract][Full Text] [Related]
5. Crystal and molecular structure of the inhibitor eglin from leeches in complex with subtilisin Carlsberg. McPhalen CA; Schnebli HP; James MN FEBS Lett; 1985 Aug; 188(1):55-8. PubMed ID: 3926539 [TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics refinement of a thermitase-eglin-c complex at 1.98 A resolution and comparison of two crystal forms that differ in calcium content. Gros P; Betzel C; Dauter Z; Wilson KS; Hol WG J Mol Biol; 1989 Nov; 210(2):347-67. PubMed ID: 2689655 [TBL] [Abstract][Full Text] [Related]
7. Refined crystal structures of subtilisin novo in complex with wild-type and two mutant eglins. Comparison with other serine proteinase inhibitor complexes. Heinz DW; Priestle JP; Rahuel J; Wilson KS; Grütter MG J Mol Biol; 1991 Jan; 217(2):353-71. PubMed ID: 1992167 [TBL] [Abstract][Full Text] [Related]
8. Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo. McPhalen CA; James MN Biochemistry; 1988 Aug; 27(17):6582-98. PubMed ID: 3064813 [TBL] [Abstract][Full Text] [Related]
9. Two-dimensional NMR studies of Kazal proteinase inhibitors. 1. Sequence-specific assignments and secondary structure of turkey ovomucoid third domain. Robertson AD; Westler WM; Markley JL Biochemistry; 1988 Apr; 27(7):2519-29. PubMed ID: 3164216 [TBL] [Abstract][Full Text] [Related]
10. X-ray crystal structure of the serine proteinase inhibitor eglin c at 1.95 A resolution. Hipler K; Priestle JP; Rahuel J; Grütter MG FEBS Lett; 1992 Sep; 309(2):139-45. PubMed ID: 1505678 [TBL] [Abstract][Full Text] [Related]
11. Refined 1.2 A crystal structure of the complex formed between subtilisin Carlsberg and the inhibitor eglin c. Molecular structure of eglin and its detailed interaction with subtilisin. Bode W; Papamokos E; Musil D; Seemueller U; Fritz H EMBO J; 1986 Apr; 5(4):813-8. PubMed ID: 3519213 [TBL] [Abstract][Full Text] [Related]
12. Structure of the proteinase inhibitor eglin c with hydrolysed reactive centre at 2.0 A resolution. Betzel C; Dauter Z; Genov N; Lamzin V; Navaza J; Schnebli HP; Visanji M; Wilson KS FEBS Lett; 1993 Feb; 317(3):185-8. PubMed ID: 8425603 [TBL] [Abstract][Full Text] [Related]
13. Mapping of the spectral densities of N-H bond motions in eglin c using heteronuclear relaxation experiments. Peng JW; Wagner G Biochemistry; 1992 Sep; 31(36):8571-86. PubMed ID: 1390643 [TBL] [Abstract][Full Text] [Related]
14. Active site binding loop stabilization in the subtilisin inhibitor eglin c: structural and functional studies on specifically designed mutants in complex with subtilisin and the uncomplexed inhibitor. Hipler K; Priestle JP; Rahuel J; Grütter MG Adv Exp Med Biol; 1996; 379():43-7. PubMed ID: 8796309 [TBL] [Abstract][Full Text] [Related]
15. Proton NMR assignments and secondary structure of the snake venom protein echistatin. Chen Y; Pitzenberger SM; Garsky VM; Lumma PK; Sanyal G; Baum J Biochemistry; 1991 Dec; 30(50):11625-36. PubMed ID: 1661142 [TBL] [Abstract][Full Text] [Related]
16. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to serine (pro)enzymes: a comparative thermodynamic study. Ascenzi P; Aducci P; Amiconi G; Ballio A; Guaragna A; Menegatti E; Schnebli HP; Bolognesi M J Mol Recognit; 1991; 4(4):113-9. PubMed ID: 1799460 [TBL] [Abstract][Full Text] [Related]
17. Effects of eglin-c binding to thermitase: three-dimensional structure comparison of native thermitase and thermitase eglin-c complexes. Gros P; Teplyakov AV; Hol WG Proteins; 1992 Jan; 12(1):63-74. PubMed ID: 1553381 [TBL] [Abstract][Full Text] [Related]
18. A 1H NMR probe for mobility in the reactive center loops of serpins: spin-echo studies of native and modified forms of ovalbumin and alpha 1-proteinase inhibitor. Hood DB; Gettins P Biochemistry; 1991 Sep; 30(37):9054-60. PubMed ID: 1892818 [TBL] [Abstract][Full Text] [Related]
19. Stereospecific assignments of side-chain protons and characterization of torsion angles in Eglin c. Hyberts SG; Märki W; Wagner G Eur J Biochem; 1987 May; 164(3):625-35. PubMed ID: 3032625 [TBL] [Abstract][Full Text] [Related]
20. Complex between the subtilisin from a mesophilic bacterium and the leech inhibitor eglin-C. Dauter Z; Betzel C; Genov N; Pipon N; Wilson KS Acta Crystallogr B; 1991 Oct; 47 ( Pt 5)():707-30. PubMed ID: 1793542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]